Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

13.0K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
13.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of Immune Responses Against AAV Encoded Transgene Products.

The AAPS journal·2026
Same author

Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference Workshops.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2025
Same author

Performance and Stability of New Class of Fetal Bovine Sera (FBS) and Its Lyophilized Form in ELISpot and FluoroSpot Assays: Applications for Monitoring the Immune Response in Vaccine, and Cell and Gene Immunotherapy in Clinical Trials.

Methods in molecular biology (Clifton, N.J.)·2024
Same author

Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy.

The AAPS journal·2023
Same author

Validation of the performance and suitability of a new class of FBS optimized for use in single-cell functional assays.

Journal of immunological methods·2023
Same author

Monitoring cell-mediated immune responses in AAV gene therapy clinical trials using a validated IFN-γ ELISpot method.

Molecular therapy. Methods & clinical development·2021

Related Experiment Video

Updated: Jun 30, 2025

Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
06:13

Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens

Published on: November 23, 2010

34.8K

Important Considerations for ELISpot Validation.

Sylvia Janetzki1

  • 1ZellNet Consulting, Inc., Fort Lee, NJ, USA. sylvia@zellnet.com.

Methods in Molecular Biology (Clifton, N.J.)
|March 19, 2024
PubMed
Summary

The Enzyme-Linked ImmunoSpot (ELISpot) assay is a valuable tool for immune monitoring. This chapter clarifies ELISpot validation parameters for consistent and reliable results in research and clinical settings.

Keywords:
AccuracyELISpotELISpot validationLimit of DetectionPrecisionRobustnessSpecificity

More Related Videos

The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity
08:26

The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity

Published on: December 14, 2016

15.2K
Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

15.8K

Related Experiment Videos

Last Updated: Jun 30, 2025

Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
06:13

Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens

Published on: November 23, 2010

34.8K
The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity
08:26

The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity

Published on: December 14, 2016

15.2K
Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

15.8K

Area of Science:

  • Immunology
  • Biotechnology
  • Assay Development

Background:

  • The Enzyme-Linked ImmunoSpot (ELISpot) assay has been a cornerstone of immune monitoring for over four decades.
  • It offers a straightforward method for assessing single immune cell function, widely applied in basic, translational, and clinical research.
  • Existing harmonization guidelines support optimal assay performance, yet protocol validation remains subject to varied interpretations.

Purpose of the Study:

  • To address the critical need for standardized validation of established ELISpot protocols.
  • To provide clear interpretations of validation parameters for a comprehensive description of assay performance.
  • To enhance the reliability and reproducibility of ELISpot assay results across diverse research applications.

Main Methods:

  • Discussion and critical review of established ELISpot validation parameters.
  • Analysis of diverse opinions and approaches to interpreting validation data.
  • Proposal of considerations for meaningful description of assay performance.

Main Results:

  • Identified variability in the interpretation of ELISpot validation parameters.
  • Highlighted the importance of consistent interpretation for accurate assay performance description.
  • Provided a framework for addressing key considerations in ELISpot validation.

Conclusions:

  • Standardized interpretation of ELISpot validation parameters is essential for reliable immune monitoring.
  • This chapter offers guidance to harmonize validation practices, improving assay reproducibility.
  • Consistent validation ensures meaningful data interpretation in immunological research and clinical applications.